Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

ItalyBack to Italy

Clinical trials in Conegliano

6 clinical trials in Conegliano, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.

ItalyOur site in ItalyStudi-Clinici.it(opens in a new tab)
Conegliano at a glance
6
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

6 trials in Conegliano

Open in trial search

Cerebral palsy

Recruiting

Study of Cenegermin Nasal Spray for Safety and Tolerability in Children with Spastic Cerebral Palsy

Investigational
Countries:ItalyItaly
  • Participants:0–17 years
  • Substances:Cenegermin
  • Sponsor:Dompe' Farmaceutici S.p.A.

Generalised tonic-clonic seizure+1

Recruiting

Study of PRAX-628 to evaluate safety and effectiveness in adults with epilepsy who have focal seizures or generalized tonic-clonic seizures

InvestigationalNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:PRAX-628
  • Sponsor:Praxis Precision Medicines Inc.

Partial seizures

Not yet recruiting

A study to evaluate the effectiveness and safety of vormatrigine in adults with focal epilepsy who are taking one to three anti-seizure medications.

Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Vormatrigine
  • Sponsor:Praxis Precision Medicines Inc.

Pulmonary embolism+1

Not yet recruiting

Study on Sulodexide for Preventing Recurrence of Blood Clots in Elderly Patients After First Episode of Deep Vein Thrombosis or Pulmonary Embolism

Registered drug
Countries:ItalyItaly
  • Participants:65+ years
  • Substances:Sulodexide
  • Sponsor:Fondazione Arianna Anticoagulazione

Type 2 diabetes mellitus

Not recruiting

Study on the Safety and Effectiveness of Metformin Hydrochloride, Dapagliflozin, and Canagliflozin in Elderly Patients with Type 2 Diabetes

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:65+ years
  • Substances:Canagliflozin
  • Sponsor:Center For Outcomes Research And Clinical Epidemiology S.r.l.

Partial seizures

Not recruiting

Study on PRAX-628 for Adults with Focal Epilepsy Taking 1 to 3 Anti-Seizure Medications

Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:PRAX-628
  • Sponsor:Praxis Precision Medicines Inc.

Other cities in Italy

The busiest research cities in the country

All 237 cities in Italy

Clinical research in Conegliano

What the registry says about research in the country

01 Diabetes Management

Innovative research focusing on SGLT2 inhibitors in elderly patients with Type 2 diabetes mellitus, aiming to optimize glycemic control while preventing hypoglycemic events.

  • Blood glucose management
  • Elderly patient care
  • Medication safety assessment

The study evaluates treatment effectiveness over a 24-month period, specifically targeting individualized HbA1c goals.

02 Cardiovascular Health

Clinical investigation of sulodexide in the prevention of recurring venous thromboembolism, specifically designed for elderly patients aged 75 and above.

  • Thrombosis prevention
  • Geriatric medicine
  • Blood vessel health

The research focuses on both efficacy and safety, with particular attention to bleeding risk assessment.

03 Neurological Disorders

Advanced clinical research evaluating a novel therapeutic approach for patients with focal epilepsy, testing the effectiveness of PRAX-628 in combination with existing treatments.

  • Seizure management
  • Anticonvulsant therapy
  • Neurological treatment

This study aims to enhance seizure control in adults currently using multiple anti-seizure medications.

Back to ItalyAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.